BeOne Medicines

Highly Engaged Employees

BeOne Medicines is a global biotechnology company founded in 2010, dedicated to developing next-generation cancer treatments through pioneering research and advanced therapies. Operating within the Pharmaceuticals and Healthcare sectors, the company's core mission is to make life-saving treatments accessible to patients worldwide, prioritizing speed, equity, and affordability. With a commitment to a global perspective, BeOne Medicines strives to overcome geographical barriers in cancer care. The company's operations span 32 locations, supporting its extensive research and development efforts. Learn about BeOne Medicines's global headquarters for detailed geographic insights into its operational footprint. With an employee base exceeding 10,000 individuals, BeOne Medicines fosters a robust team dedicated to scientific advancement and patient outcomes. Meet BeOne Medicines's team to understand the expertise driving their innovative pipeline.

The company's financial standing is robust, reporting revenue of $5.7B. BeOne Medicines has secured substantial funding throughout its growth, including significant rounds such as a $1.0B Private Equity investment and a $2.8B Share Placement, underscoring investor confidence in its mission and potential. Its product portfolio includes commercial-stage and clinical-stage biopharmaceutical assets focused on oncology. The company leverages science-driven biotechnology to develop novel treatments, aiming for best-in-class therapeutic outcomes. BeOne Medicines is actively engaged in clinical development and commercialization, seeking approvals for its innovative candidates. Explore financial highlights to delve deeper into its financial performance and investment history. The company's strategic focus on oncology and global accessibility positions it as a key player in advancing cancer care solutions.